Food expert Lynette Johnston, PhD, provides some context around the ongoing outbreak, discusses prevention, and compares 2026 food recalls with previous years.
|Videos|June 3, 2017
What Are Some Causes of Antimicrobial Shortages?
Author(s)Contagion Editorial Staff
Milena McLaughlin, PharmD, MSc, explains the main causes of antimicrobial shortages.
Advertisement
Milena McLaughlin, PharmD, MSc, assistant professor, Pharmacy Practice, Midwestern State University, Northwestern Memorial Hospital, explains the main causes of antimicrobial shortages.
Interview Transcript (slightly modified for readability)
“The main causes of antimicrobial shortages can be broken down into two different frames. So, there are decreased supply issues such as manufacturing issues, if they can’t get the active ingredients, or regulatory issues, if they can’t have one of their lines inspected, and then there is increase demand. So, if there’s a drug that goes on shortage and then there’s an alternative to that drug, everyone’s going to be buying that alternative and then that drug would then go on shortage. The drugs at greatest risk for a shortage would be generic injectable medications that have a single manufacturer.”
Advertisement
Related to this article
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
Resistance-guided testing targeting a single gene mutation could let clinicians safely reintroduce ciprofloxacin for the majority of gonorrhea cases still susceptible to it, sparing ceftriaxone as resistance climbs worldwide. Lao-Tzu Allan-Blitz, MD, MPH, offers insights into his work in this area.
In the third episode of the series with Perry N. Halkitis, PhD, MS, MPH, he discusses how human behavior as well as other factors play a significant role in repeating outbreaks.
In the second episode of the series with Perry N. Halkitis, PhD, MS, MPH, he brings his personal experience to this topic and questions whether there should be a shift in who manages the primary care needs of these patients.
Gavin Harris, MD, provides some context around what is happening in the Democratic Republic of Congo regarding the outbreak including the country’s inherent challenges as well as discussing the latest in testing, vaccines, and treatments of this rare strain of Ebola.
The phase 3 priMe trial found the investigational vaccine did not demonstrate noninferiority for preventing tuberculosis infection, though the study authors cited surrogate end point and exposure-imbalance issues that complicate interpretation.
Advertisement
Advertisement
Trending on Contagion Live
1
Revisiting Whether Cefepime Raises Mortality Risk
2
A Pennsylvania Teen Dies From Rare Measles Neurological Complication
3
New York City Orders Tower Cleanings, Announces Prevention Measures in Addressing Legionnaires' Disease Cluster
4
Ceftriaxone Safety: Separating Signal From Risk
5